Classical QSAR and Docking Simulation of 4-Pyridone Derivatives for Their Antimalarial Activity
暂无分享,去创建一个
Jesús Lezama | Edgar Márquez | E. Márquez | Máryury Flores-Sumoza | Jackson J Alcázar | José R Mora | Esneyder Puello | Esneyder Puello | Jesús Lezama | J. Mora | Máryury Flores-Sumoza | Jackson J. Alcázar
[1] J. Vidal,et al. Potent antimalarial 4-pyridones with improved physico-chemical properties. , 2011, Bioorganic & medicinal chemistry letters.
[2] M. Mather,et al. Mitochondrial drug targets in apicomplexan parasites. , 2007, Current drug targets.
[3] James M. Woolven,et al. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials. , 2008, Journal of medicinal chemistry.
[4] Gene H. Golub,et al. Generalized cross-validation as a method for choosing a good ridge parameter , 1979, Milestones in Matrix Computation.
[6] N. Meanwell. Synopsis of some recent tactical application of bioisosteres in drug design. , 2011, Journal of medicinal chemistry.
[7] P. Geerlings,et al. Conceptual density functional theory. , 2003, Chemical reviews.
[8] V. Barton,et al. Inhibiting Plasmodium cytochrome bc1: a complex issue. , 2010, Current opinion in chemical biology.
[9] T. Egan. Interactions of quinoline antimalarials with hematin in solution. , 2006, Journal of inorganic biochemistry.
[10] E. LaVoie,et al. Bioisosterism: A Rational Approach in Drug Design. , 1996, Chemical reviews.
[11] P. Pascutti,et al. Insights into cytochrome bc 1 complex binding mode of antimalarial 2-hydroxy-1,4-naphthoquinones through molecular modelling , 2017, Memorias do Instituto Oswaldo Cruz.
[12] Dennis E. Grawoig,et al. Statistics, a foundation for analysis , 1972, The Mathematical Gazette.
[13] David A. Winkler,et al. The role of quantitative structure-activity relationships (QSAR) in biomolecular discovery , 2002, Briefings Bioinform..
[14] Nancy Fullman,et al. Global malaria mortality between 1980 and 2010: a systematic analysis , 2012, The Lancet.
[15] C. Davis,et al. Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor. , 2006, Journal of pharmaceutical sciences.
[16] R. C. Young,et al. Dipole moment in relation to H2 receptor histamine antagonist activity for cimetidine analogues. , 1986, Journal of medicinal chemistry.
[17] E. Márquez,et al. Molecular modeling studies of bromopyrrole alkaloids as potential antimalarial compounds: a DFT approach , 2018, Medicinal Chemistry Research.
[18] B. Trumpower,et al. Specific roles of protein–phospholipid interactions in the yeast cytochrome bc1 complex structure , 2001, The EMBO journal.
[19] Joanne M. Morrisey,et al. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum , 2007, Nature.
[20] S. Meshnick,et al. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi. , 2007, Trends in parasitology.
[21] Martin Hofmann-Apitius,et al. In silico drug discovery approaches on grid computing infrastructures. , 2010, Current clinical pharmacology.
[22] D. Warhurst,et al. Antimalarial drug discovery: development of inhibitors of dihydrofolate reductase active in drug resistance , 1998 .
[23] S. Meshnick,et al. Molecular Basis for Atovaquone Binding to the Cytochrome bc1 Complex* , 2003, Journal of Biological Chemistry.
[24] A. Toro‐Labbé,et al. Relations between Potential Energy, Electronic Chemical Potential, and Hardness Profiles , 1997 .
[25] W J Dunn,et al. Linear relationships between lipophilic character and biological activity of drugs. , 1972, Journal of pharmaceutical sciences.
[26] K. Roy,et al. Advances in quantitative structure–activity relationship models of antimalarials , 2010, Expert opinion on drug discovery.
[27] BioChem Press,et al. Predictive Comparative QSAR Modeling of 4-Pyridones as Potent Antimalarials , 2010 .
[28] L. Mammino,et al. Computational study of naphthylisoquinoline alkaloids with antimalarial activity from Dioncophyllaceae and Ancistrodaceae in vacuo , 2016, Theoretical Chemistry Accounts.
[29] T. J. Villalobos,et al. 2D, 3D-QSAR and molecular docking of 4(1H)-quinolones analogues with antimalarial activities. , 2013 .
[30] G. Moreau,et al. Rational approach to drug design , 2008 .
[31] Andrew Owen,et al. Acridinediones: Selective and Potent Inhibitors of the Malaria Parasite Mitochondrial bc1 Complex , 2008, Molecular Pharmacology.
[32] R. Mannhold,et al. Calculation of molecular lipophilicity: state of the art and comparison of methods on more than 96000 compounds , 2009, Journal of pharmaceutical sciences.
[33] Jonathan L. Vennerstrom,et al. Structural Analysis of Chloroquine Resistance Reversal by Imipramine Analogs , 2001, Antimicrobial Agents and Chemotherapy.
[34] R. Parr,et al. Principle of maximum hardness , 1991 .
[35] Biological Activity of Chemical Compounds and Their Molecular Structure-Information Approach , 2014 .
[36] R. Pearson. Chemical hardness and the electronic chemical potential , 1992 .
[37] José R. Mora,et al. Theoretical calculations on the mechanisms of the gas phase elimination kinetics of chlorocyclohexane, 3-chlorocyclohexene and 4-chlorocyclohexene , 2009 .
[38] Michael J. Frisch,et al. The performance of the Becke-Lee-Yang-Parr (B-LYP) density functional theory with various basis sets , 1992 .
[39] J. A. Paixão,et al. Quinolone-Hydroxyquinoline Tautomerism in Quinolone 3-Esters. Preserving the 4-Oxoquinoline Structure To Retain Antimalarial Activity. , 2015, The Journal of organic chemistry.
[40] Wei-Chun Kao,et al. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action , 2014, Nature Communications.
[41] K. Kita,et al. Parasite Mitochondria as a Target of Chemotherapy: Inhibitory Effect of Licochalcone A on the Plasmodium falciparum Respiratory Chain , 2005, Annals of the New York Academy of Sciences.